HIGHLIGHTS
- who: Benjamin Verret et al. from the Medical Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy have published the research: The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling, in the Journal: Cancers 2022, 14, 4203. of /2022/
- what: To validating the ctDNA monitoring strategy and early treatment intervention, this study provided a prospective validation of ESR1 mutation with regards to biomarker aromatase inhibitor resistance and fulvestrant sensitivity.
- future: This statement is likely to change in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.